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• Tuberculosis (TB) occurs in every part of the world as a top
infectious disease killer.
• In 2014, 9.6 million cases (an estimated 1 million children)
and 1.5 million deaths (140 000 children) from TB were
registered. Over 95% of TB deaths occur in developing
countries.
• TB incidence has fallen since 2000 and is now 18% lower,
by an average of 1.5% per year.
OBJECTIVE
• To give overview on contemporary microbiological 
diagnostic tests for rapid identification and detection of  
resistance of Mycobacterium tuberculosis
• To present possibilities of microbiological diagnostic tests 
for identification and detection of  resistance of 
Mycobacterium tuberculosis in National laboratory in         
Republic of Macedonia
• To present data of results of some methods for rapid 
identification and detection of  resistance of 
Mycobacterium tuberculosis
• TB is a treatable and curable disease with a standard 6 
month protocol of 4 antimicrobial drugs. In cases of multi-
drug resistant TB (MDR-TB ) responds are very week 
including the most effective second-line anti-TB drugs. 
About 480 000 people developed MDR-TB in the world in 
2014.
• Standard anti-TB drugs have been used for decades, and 
resistance to a single anti-TB drug have been documented 
in every country worldwide. 
• Multidrug-resistant tuberculosis (MDR-TB) is a form of TB 
caused by bacteria that do not respond to, at least, isoniazid 
and rifampicin, the 2 most powerful, first-line (or standard) 
anti-TB drugs. 
Preparing staining and culture 
WHO Goal target is ending the TB epidemic by 2030
MATERIAL and METHODS
• Material and methods in use in National reference laboratory of 
Republic of Macedonia (microbiological laboratory at the 
Institute for lung diseases).
• Standard methods in use:
• Culture on Lővenstein-Jensen medium 
• Ziehl - Neelsen staining/ or Cold staining- Kinyon method
• Antitubreculotic drugs susceptibility testing on modified 
Lővenstein-Jensen medium for:
• Isoniazid (H) 0,2 µg/l
• Rifampicin ® 40,0 µg/l
• Ethambutol (E) 2,0 µg/l
• Streptomycin (S) 4,0 µg/l
• Contemporary methods:
• Bactec MGIT 960
Is an automated method enable identification of Mycobacterium 
tuberculosis for 4-12 -20 days, and susceptibility testing on : 
streptomycin, isoniazid, rifampicin, ethambutol and 
pyrazinamide, and tests for antituberculosis drug of second line.
Bactec MGIT 960
• GeneXpert
WHO monitoring Xpert MTB/RIF,  managed by the WHO Global 
TB Program, is an automated, cartridge-based nucleic 
amplification assay for the simultaneous detection of TB and 
rifampicin resistance directly from sputum in under two 
hours.  The technology is based on the GeneXpert platform
•RESULTS
Year 2010 2011 2012 2013 2014
Positive 502 350 428 376 375
Negative 5339 5594 5519 6060 6061
Year 2010 2011 2012 2013 2014
Positive 52 62 86 77 ?
Negative 335 433 569 835 ?
Bactec MGIT 960   results
Culture results on Lővenstein-Jensen medium
Year 2009 2010 2011 2012 2013 2014
TB strains 191(100%) 181(100%) 155(100%) 181(100%) 198(100%) 154(100)
Sensitive 175(91,6%) 170(93,9%) 143(92,2%) 163(90%) 191(96,4%) 142(92,%)
Resistant 16 (8,3%) 11 (6%) 12 (7,7%) 18 (10%) 7 (3,5%) 12 (7,5%)
Mono-resistant 14 (7,3%) 3 (1,6%) 9 (5,8%) 11 (6%) 6  (3%) 10 (5,8%)
Rifampicin
resistant
3 (1,5%) / 5 (3,2%) 1 (0,5%) 1 (0,5%) 3 (1,7%)
MDR 1 (0,5%) 7 (3,8%) 1 (0,6%) 4(2,2%) 1 (0,5%) 2 (1,2%)
TB resistance over period 2009-2014
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CONCLUSIONS
 In National reference laboratory for Identification and Detection of  Resistance of Mycobacterium 
tuberculosis, beside standard methods, contemporary rapid methods recommended by WHO 
experts and Global TB Program, such are Bactec MGIT and GeneXpert are priority.
 Rapid methods enable final diagnosis of TB, including isolation, identification and susceptibility 
testing in significantly shorter time.
 Number of new TB infections in Republic of Macedonia is decreasing continuously in past 10 
years. 
 MDR strains in Republic of Macedonia are at low level.
Conte porary methods:
• Bactec MGIT 960
Is an automated method enable identification of 
Mycobacterium tuberculosis for 4-12 -20 da s, and 
susceptibility testing on : streptomycin, isoniazid, 
rifampicin, ethambutol and pyrazinamide, and tests for 
antituberculosis drug of second line.
• In National ref r nce laboratory for Identification and t ti   esistance of Mycobacterium 
tuberculosis, beside standard Methods, contemporary rapid methods recommended by WHO Experts 
and Global TB Pr gram, such are: Ba tec MGIT and GeneXpert ar  priority.
• Rapid methods enable final diagnosis of TB, including isolation, identification and susceptibility 
testing in significantly shorter t me.
• Number of new TB infections in Republic of Macedonia is decreasing continuously in past 10 years. 
• MDR strains in Republic of Macedonia are at low level.
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